LexDanaLexDanabeta
Inventor

Po-Wai Yuen

Inventor
Ann Arbor, MI, US

Overview

54→
Patents
1992–2020
Patent span
Chemistry
Primary field (CPC C)

Patents· 54 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds33%
A61KPreparations for medical, dental or toiletry purposes21%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations17%
C07CAcyclic or carbocyclic compounds15%
G11BInformation storage based on relative movement between record carrier and transducer10%
B42DBooks1%
B62HCycle stands1%
B62KCycles1%
C07BGeneral methods of organic chemistry1%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests1%
PatentTitleYear
10,800,780TDO2 Inhibitors202010,772,874Compounds and compositions for the inhibition of NAMPT202010,730,889Amido spirocyclic amide and sulfonamide derivatives202010,696,692Amido-benzyl sulfone and sulfoxide derivates202010,647,731Thiazolopyrimidinones and methods of use thereof202010,647,695Compounds and compositions for the inhibition of NAMPT202010,456,382Compounds and compositions for the inhibition of NAMPT201910,329,275Compounds and compositions for the inhibition of NAMPT201910,272,072Compounds and compositions for the inhibition of NAMPT20199,988,400Thiazolopyrimidinones and methods of use thereof20189,873,709Triazolopyridine compounds, compositions and methods of use thereof20189,822,129'Amido spirocyclic amide and sulfonamide derivatives'20179,605,005'Alkynyl alcohols and methods of use'20179,458,172'Pyridinyl and pyrimidinyl sulfoxide and sulfone derivatives'20169,346,815'5-chloro-2-difluoromethoxyphenyl pyrazolopyrimidine compounds, compositions and methods of use thereof'20169,296,732'Substituted benzamides and their uses'20169,085,570'Substituted benzamides and their uses'20158,445,684'Nicotinic acetylcholine receptor ligands and the uses thereof'20137,485,636'Therapeutic pyrazolo[3,4-b]pyridines and indazoles'20097,423,054'Therapeutic pyrazolo[3,4-b]pyridines and indazoles'20087,122,678'Cyclic amino acids and derivatives thereof useful as pharmaceutical agents'20066,976,709'Postal mailer with calling card'20056,921,835'Cyclic amino acids and derivatives thereof useful as pharmaceutical agents'20056,833,385'3-heteroarylalkyl substituted GABA analogs'20046,710,190'3-heteroarylalkyl substituted gaba analogs'20046,642,398'Mono-and disubstituted 3-propyl gamma-aminobutyric acids'20036,635,673'Cyclic amino acids and derivatives thereof useful as pharmaceutical agents'20036,571,588'Security nut and key assembly'20036,525,096'GABA and L-glutamic acid analogs for antiseizure treatment'20036,414,024'GABA and L-glutamic acid analogs for antiseizure treatment'20026,359,169'GABA and L-glutamic acid analogs for antiseizure treatment'20026,342,529'GABA and L-glutamic acid analogs for antiseizure treatment'20026,291,526'GABA and L-glutamic acid analogs for antiseizure treatment'20016,255,345'GABA and L-glutamic acid analogs for antiseizure treatment'20016,140,366'GABA and L-glutamic acid analogs for antiseizure treatment'20006,124,280'Substituted phenols as novel calcium channel blockers'20006,124,323'4-substituted piperidine analogs and their use as subtype selective NMDA receptor antagonists'20006,117,906'GABA and L-glutamic acid analogs for antiseizure treatment'20006,110,911'Cyclic amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists'20006,028,214'GABA and L-glutamic acid analogs for antiseizure treatment'20005,932,573'Substituted quinolines and isoquinolines as calcium channel blockers, their preparation and the use thereof'19995,874,426'Cyclic amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists'19995,847,151'Gaba and L-glutamic acid analogs for antiseizure treatment'19985,767,129'Substituted quinolines and isoquinolines as calcium channel blockers, their preparation and the use thereof'19985,760,048'Alpha-mercaptoacrylic acid derivatives having calpain inhibitory activity'19985,710,304'GABA and L-glutamic acid analogs for antiseizure treatment'19985,684,189'GABA and L-glutamic acid analogs for antiseizure treatment'19975,679,680'.alpha.-substituted hydrazides having calpain inhibitory activity'19975,608,090'GABA and L-glutamic acid analogs for antiseizure treatment'19975,599,973'GABA and L-glutamic acid analogs for antiseizure treatment'19975,563,175'GABA and L-glutamic acid analogs for antiseizure treatment'19965,554,767'Alpha-mercaptoacrylic acid derivatives having calpain inhibitory activity'19965,284,862'Derivatives of 2-carboxyindoles having pharmaceutical activity'19945,145,845'Substituted 2-carboxylindoles having pharmaceutical activity'1992

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1992–2008Patents assigned to WARNER LAMBERT CO (32)· patent assignee history
1992–2018Based in Ann Arbor, MI, US· patent location history
1996–2003Patents assigned to UNIV NORTHWESTERN (15)· patent assignee history
2003–2005Based in Scarsdale, NY, US· patent location history
2013–2017Patents assigned to YUEN PO-WAI (4)· patent assignee history
2016–2020Patents assigned to GENENTECH INC (14)· patent assignee history
2016–2020Based in Beijing, CN· patent location history
2017–2020Patents assigned to FORMA TM LLC (8)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
WARNER LAMBERT CO321992–2008
UNIV NORTHWESTERN151996–2003
GENENTECH INC142016–2020
FORMA TM LLC82017–2020
YUEN PO-WAIself42013–2017
Locations
LocationPatentsSpan
Ann Arbor, MI, US401992–2018
Beijing, CN122016–2020
Scarsdale, New York, US22003–2005